Maternal-Infant Transmission of Hepatitis C Virus Infection
Mother-to-infant transmission of hepatitis C virus (HCV) is comparatively
uncommon. The actual time and mode of transmission are not
known. Elective Cesarean section is not recommended for women with chronic HCV
infection alone. The role of treatment to prevent transmission is limited by the fetal
toxicity of currently available medications for hepatitis C. Breast feeding poses no
important risk of HCV transmission if nipples are not traumatized and maternal
hepatitis C is quiescent. Pregnancy women at high risk for HCV infection should be
screened for anti-HCV and HCV RNA testing should be performed if anti-HCV is
positive. Infants of women with hepatitis C should be tested for HCV RNA on two
occasions, between the ages of 2 and 6 months, and again at 18 to 24 months, along with
serum anti-HCV. The natural history of mother-to-infant hepatitis C remains uncertain,
especially the course in the first year of life when some infants appear to have
spontaneous resolution.
Hepatitis Virus in Blood and Dialysate in Hemodialysis
The prevalence of hepatitis C virus (HCV) positivity among hemodialysis
patients remains high compared with that of the healthy population, and thus the issue
of safety and environmental protection must be addressed.